
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,206 Listeners

1,706 Listeners

956 Listeners

1,940 Listeners

1,647 Listeners

1,095 Listeners

124 Listeners

320 Listeners

1,041 Listeners

1,304 Listeners

6,078 Listeners

33 Listeners

41 Listeners

20 Listeners

10 Listeners

0 Listeners

79 Listeners

18 Listeners

12 Listeners

3 Listeners